Squarepoint’s ResMed RMD Stock Holding History

Squarepoint’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-900	Closed	-$232K	–	4897
2025 Q2	$232K	Buy	+900	New	+$215K	﹤0.01%	3880
2025 Q1	–	Sell	-1,900	Closed	-$435K	–	5272
2024 Q4	$435K	Sell	1,900 -2,500	-57%	-$602K	﹤0.01%	3844
2024 Q3	$1.07M	Buy	+4,400	New	+$983K	﹤0.01%	2553
2024 Q1	–	Sell	-7,900	Closed	-$1.36M	–	4522
2023 Q4	$1.36M	Buy	+7,900	New	+$1.21M	﹤0.01%	2293

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint's RMD Position: Q1 2026 in Review

Squarepoint reduced its ResMed (RMD) stake by 97% in Q1 2026, selling an estimated $27.5M and leaving 3,872 shares worth $869K. The position accounts for ﹤0.01% of the portfolio, ranked #2902.

Squarepoint first reported a position in RMD in Q4 2015 and has held it in 30 quarters since. The position peaked at $141M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Squarepoint held 3,872 shares of ResMed worth $869K as of Q1 2026.
Squarepoint sold 110,285 ResMed shares in Q1 2026, an estimated $27.5M.
ResMed made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2902 holding.
Squarepoint first reported a position in ResMed in Q4 2015 and has held it in 30 quarters since.
Squarepoint's ResMed position peaked at $141M in Q2 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.